NASRI GHALY: Open Payments
NPI 1063479939 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$20,631 in 123 payments from 17 companies in 2025. Trend: 2023 $21,893 · 2024 $14,897 · 2025 $20,631
Speaker / faculty: $17,470Food & beverage: $2,516Consulting: $460Education: $185
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 28 | $13,094 |
| ABBVIE INC. | 16 | $5,961 |
| E.R. Squibb & Sons, L.L.C. | 19 | $398 |
| Neurocrine BioSciences, Inc. | 15 | $230 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $197 |
| Vanda Pharmaceuticals Inc. | 7 | $165 |
| Otsuka America Pharmaceutical, Inc. | 8 | $154 |
| Alkermes, Inc. | 6 | $125 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Biogen, Inc. | 3 | $62 |
Products named: AUSTEDO XR, VRAYLAR, COBENFY, INGREZZA, REXULTI, CAPLYTA, HETLIOZ, ARISTADA.
Industry payments across NY — which companies pay providers there.
